Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.62 +0.01 (+0.58%)
As of: Oct 2, 2026 · 10:03 AM EDT

Zentalis Pharmaceuticals (ZNTL) Equity Income (2021 - 2023)

Updated

Zentalis Pharmaceuticals (ZNTL) reported Equity Income of -$16.01 million for FY2023, compared with -$16.28 million in FY2022.

Analysis

Zentalis Pharmaceuticals (ZNTL) Equity Income (2021 - 2023) Analysis & Trends

  • According to Business Quant data, Equity Income came in at -$16.28 million in FY2022 and -$1.83 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Zentalis Pharmaceuticals 198.52 Mn 198.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -13.70 Mn
Mar 31, 2023 -2.31 Mn
Dec 31, 2022 -6.82 Mn
Sep 30, 2022 -2.37 Mn
Jun 30, 2022 -5.34 Mn
Mar 31, 2022 -1.75 Mn
Dec 31, 2021 -1.83 Mn
API Access

Zentalis Pharmaceuticals Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ZNTL&period=max&api_key=YOUR_API_KEY